Hokkaido University Collection of Scholarly and Academic Papers >
Central Institute of Isotope Science >
Peer-reviewed Journal Articles, etc >
In vivo imaging of membrane type-1 matrix metalloproteinase with a novel activatable near-infrared fluorescence probe
This item is licensed under:Creative Commons Attribution-NonCommercial 3.0 Unported
Title: | In vivo imaging of membrane type-1 matrix metalloproteinase with a novel activatable near-infrared fluorescence probe |
Authors: | Shimizu, Yoichi Browse this author | Temma, Takashi Browse this author →KAKEN DB | Hara, Isao Browse this author | Makino, Akira Browse this author | Kondo, Naoya Browse this author | Ozeki, Ei-ichi Browse this author | Ono, Masahiro Browse this author | Saji, Hideo Browse this author →KAKEN DB |
Keywords: | Activatable probe | membrane type-1 matrix metalloproteinase | molecular imaging | near-infrared | optical |
Issue Date: | Aug-2014 |
Publisher: | Wiley-Blackwell |
Journal Title: | Cancer Science |
Volume: | 105 |
Issue: | 8 |
Start Page: | 1056 |
End Page: | 1062 |
Publisher DOI: | 10.1111/cas.12457 |
Abstract: | Membrane type-1 matrix metalloproteinase (MT1-MMP) is a protease activating MMP-2 that mediates cleavage of extracellular matrix components and plays pivotal roles in tumor migration, invasion and metastasis. Because in vivo noninvasive imaging of MT1-MMP would be useful for tumor diagnosis, we developed a novel near-infrared (NIR) fluorescence probe that can be activated following interaction with MT1-MMP in vivo. MT1-hIC7L is an activatable fluorescence probe comprised of anti-MT1-MMP monoclonal antibodies conjugated to self-assembling polymer micelles that encapsulate NIR dyes (IC7-1, em: 858nm) at concentrations sufficient to cause fluorescence self-quenching. In aqueous buffer, MT1-hIC7L fluorescence was suppressed to background levels and increased approximately 35.5-fold in the presence of detergent. Cellular uptake experiments revealed that in MT1-MMP positive C6 glioma cells, MT1-hIC7L showed significantly higher fluorescence that increased with time as compared to hIC7L, a negative control probe lacking the anti-MT1-MMP monoclonal antibody. In MT1-MMP negative MCF-7 breast adenocarcinoma cells, both MT1-hIC7L and hIC7L showed no obvious fluorescence. In addition, the fluorescence intensity of C6 cells treated with MT1-hIC7L was suppressed by pre-treatment with an MT1-MMP endocytosis inhibitor (P<0.05). In vivo optical imaging using probes intravenously administered to tumor-bearing mice showed that MT1-hIC7L specifically visualized C6 tumors (tumor-to-background ratios: 3.8 +/- 0.3 [MT1-hIC7L] vs 3.1 +/- 0.2 [hIC7L] 48h after administration, P<0.05), while the probes showed similarly low fluorescence in MCF-7 tumors. Together, these results show that MT1-hIC7L would be a potential activatable NIR probe for specifically detecting MT1-MMP-expressing tumors. |
Rights: | http://creativecommons.org/licenses/by-nc/3.0/deed.ja |
Type: | article |
URI: | http://hdl.handle.net/2115/57297 |
Appears in Collections: | アイソトープ総合センター (Central Institute of Isotope Science) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)
|
Submitter: 志水 陽一
|